Global Prophylactic Human Vaccines Sales Market Report 2016

September 2016 | 128 pages | ID: G9664E43D3CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Prophylactic Human Vaccines

Revenue, means the sales value of Prophylactic Human Vaccines

This report studies sales (consumption) of Prophylactic Human Vaccines in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia,I50 focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• ALK - Abello A/S (Denmark)
• Altimmune, Inc. (US)
• Bavarian Nordic A/S (Denmark)
• BiondVax Pharmaceuticals Ltd. (Israel)
• Bharat Biotech International Limited (India)
• GlaxoSmithKline Plc. (UK)
• Hualan Biological Engineering Inc. (China)
• Janssen Pharmaceuticals, Inc. (US)
• MedImmune (US)
• Merck & Co., Inc. (US)
• Pfizer Inc. (US)
• Sanofi Pasteur SA (France)
• Serum Institute of India Pvt. Ltd. (India)
• Shanghai BravoBio Co., Ltd. (China)
• Seqirus (UK)
• SK Chemicals Co., Ltd. (Korea)
• Takeda Pharmaceutical Company Limited (Japan)
• Zydus Cadila (India)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Prophylactic Human Vaccines in these regions, from 2011 to 2021 (forecast), like

• USA
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Prophylactic Human Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Prophylactic Human Vaccines Sales Market Report 2016

1 PROPHYLACTIC HUMAN VACCINES OVERVIEW

1.1 Product Overview and Scope of Prophylactic Human Vaccines
1.2 Classification of Prophylactic Human Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Prophylactic Human Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Prophylactic Human Vaccines Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Prophylactic Human Vaccines (2011-2021)
  1.5.1 Global Prophylactic Human Vaccines Sales and Growth Rate (2011-2021)
  1.5.2 Global Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)

2 GLOBAL PROPHYLACTIC HUMAN VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Prophylactic Human Vaccines Market Competition by Manufacturers
  2.1.1 Global Prophylactic Human Vaccines Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Prophylactic Human Vaccines Revenue and Share by Manufacturers (2011-2016)
2.2 Global Prophylactic Human Vaccines (Volume and Value) by Type
  2.2.1 Global Prophylactic Human Vaccines Sales and Market Share by Type (2011-2016)
  2.2.2 Global Prophylactic Human Vaccines Revenue and Market Share by Type (2011-2016)
2.3 Global Prophylactic Human Vaccines (Volume and Value) by Regions
  2.3.1 Global Prophylactic Human Vaccines Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Prophylactic Human Vaccines Revenue and Market Share by Regions (2011-2016)
2.4 Global Prophylactic Human Vaccines (Volume) by Application

3 USA PROPHYLACTIC HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

3.1 USA Prophylactic Human Vaccines Sales and Value (2011-2016)
  3.1.1 USA Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
  3.1.2 USA Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
  3.1.3 USA Prophylactic Human Vaccines Sales Price Trend (2011-2016)
3.2 USA Prophylactic Human Vaccines Sales and Market Share by Manufacturers
3.3 USA Prophylactic Human Vaccines Sales and Market Share by Type
3.4 USA Prophylactic Human Vaccines Sales and Market Share by Application

4 CHINA PROPHYLACTIC HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

4.1 China Prophylactic Human Vaccines Sales and Value (2011-2016)
  4.1.1 China Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
  4.1.2 China Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
  4.1.3 China Prophylactic Human Vaccines Sales Price Trend (2011-2016)
4.2 China Prophylactic Human Vaccines Sales and Market Share by Manufacturers
4.3 China Prophylactic Human Vaccines Sales and Market Share by Type
4.4 China Prophylactic Human Vaccines Sales and Market Share by Application

5 EUROPE PROPHYLACTIC HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Prophylactic Human Vaccines Sales and Value (2011-2016)
  5.1.1 Europe Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
  5.1.2 Europe Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Prophylactic Human Vaccines Sales Price Trend (2011-2016)
5.2 Europe Prophylactic Human Vaccines Sales and Market Share by Manufacturers
5.3 Europe Prophylactic Human Vaccines Sales and Market Share by Type
5.4 Europe Prophylactic Human Vaccines Sales and Market Share by Application

6 JAPAN PROPHYLACTIC HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Prophylactic Human Vaccines Sales and Value (2011-2016)
  6.1.1 Japan Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
  6.1.2 Japan Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Prophylactic Human Vaccines Sales Price Trend (2011-2016)
6.2 Japan Prophylactic Human Vaccines Sales and Market Share by Manufacturers
6.3 Japan Prophylactic Human Vaccines Sales and Market Share by Type
6.4 Japan Prophylactic Human Vaccines Sales and Market Share by Application

7 INDIA PROPHYLACTIC HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 India Prophylactic Human Vaccines Sales and Value (2011-2016)
  7.1.1 India Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
  7.1.2 India Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
  7.1.3 India Prophylactic Human Vaccines Sales Price Trend (2011-2016)
7.2 India Prophylactic Human Vaccines Sales and Market Share by Manufacturers
7.3 India Prophylactic Human Vaccines Sales and Market Share by Type
7.4 India Prophylactic Human Vaccines Sales and Market Share by Application

8 SOUTHEAST ASIA PROPHYLACTIC HUMAN VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Prophylactic Human Vaccines Sales and Value (2011-2016)
  8.1.1 Southeast Asia Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Prophylactic Human Vaccines Sales Price Trend (2011-2016)
8.2 Southeast Asia Prophylactic Human Vaccines Sales and Market Share by Manufacturers
8.3 Southeast Asia Prophylactic Human Vaccines Sales and Market Share by Type
8.4 Southeast Asia Prophylactic Human Vaccines Sales and Market Share by Application

9 GLOBAL PROPHYLACTIC HUMAN VACCINES MANUFACTURERS ANALYSIS

9.1 ALK - Abello A/S (Denmark)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Prophylactic Human Vaccines Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Altimmune, Inc. (US)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 128 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Altimmune, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Bavarian Nordic A/S (Denmark)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 143 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 BiondVax Pharmaceuticals Ltd. (Israel)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Aug Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Bharat Biotech International Limited (India)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Bharat Biotech International Limited (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 GlaxoSmithKline Plc. (UK)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Hualan Biological Engineering Inc. (China)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharmaceuticals Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Janssen Pharmaceuticals, Inc. (US)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 MedImmune (US)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 MedImmune (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Merck & Co., Inc. (US)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Merck & Co., Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Pfizer Inc. (US)
9.12 Sanofi Pasteur SA (France)
9.13 Serum Institute of India Pvt. Ltd. (India)
9.14 Shanghai BravoBio Co., Ltd. (China)
9.15 Seqirus (UK)
9.16 SK Chemicals Co., Ltd. (Korea)
9.17 Takeda Pharmaceutical Company Limited (Japan)
9.18 Zydus Cadila (India)

10 PROPHYLACTIC HUMAN VACCINES MAUFACTURING COST ANALYSIS

10.1 Prophylactic Human Vaccines Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Prophylactic Human Vaccines

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Prophylactic Human Vaccines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Prophylactic Human Vaccines Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL PROPHYLACTIC HUMAN VACCINES MARKET FORECAST (2016-2021)

14.1 Global Prophylactic Human Vaccines Sales, Revenue Forecast (2016-2021)
14.2 Global Prophylactic Human Vaccines Sales Forecast by Regions (2016-2021)
14.3 Global Prophylactic Human Vaccines Sales Forecast by Type (2016-2021)
14.4 Global Prophylactic Human Vaccines Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Human Vaccines
Table Classification of Prophylactic Human Vaccines
Figure Global Sales Market Share of Prophylactic Human Vaccines by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Prophylactic Human Vaccines
Figure Global Sales Market Share of Prophylactic Human Vaccines by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)
Figure China Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)
Figure India Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)
Figure Global Prophylactic Human Vaccines Sales and Growth Rate (2011-2021)
Figure Global Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)
Table Global Prophylactic Human Vaccines Sales of Key Manufacturers (2011-2016)
Table Global Prophylactic Human Vaccines Sales Share by Manufacturers (2011-2016)
Figure 2015 Prophylactic Human Vaccines Sales Share by Manufacturers
Figure 2016 Prophylactic Human Vaccines Sales Share by Manufacturers
Table Global Prophylactic Human Vaccines Revenue by Manufacturers (2011-2016)
Table Global Prophylactic Human Vaccines Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Prophylactic Human Vaccines Revenue Share by Manufacturers
Table 2016 Global Prophylactic Human Vaccines Revenue Share by Manufacturers
Table Global Prophylactic Human Vaccines Sales and Market Share by Type (2011-2016)
Table Global Prophylactic Human Vaccines Sales Share by Type (2011-2016)
Figure Sales Market Share of Prophylactic Human Vaccines by Type (2011-2016)
Figure Global Prophylactic Human Vaccines Sales Growth Rate by Type (2011-2016)
Table Global Prophylactic Human Vaccines Revenue and Market Share by Type (2011-2016)
Table Global Prophylactic Human Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prophylactic Human Vaccines by Type (2011-2016)
Figure Global Prophylactic Human Vaccines Revenue Growth Rate by Type (2011-2016)
Table Global Prophylactic Human Vaccines Sales and Market Share by Regions (2011-2016)
Table Global Prophylactic Human Vaccines Sales Share by Regions (2011-2016)
Figure Sales Market Share of Prophylactic Human Vaccines by Regions (2011-2016)
Figure Global Prophylactic Human Vaccines Sales Growth Rate by Regions (2011-2016)
Table Global Prophylactic Human Vaccines Revenue and Market Share by Regions (2011-2016)
Table Global Prophylactic Human Vaccines Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Prophylactic Human Vaccines by Regions (2011-2016)
Figure Global Prophylactic Human Vaccines Revenue Growth Rate by Regions (2011-2016)
Table Global Prophylactic Human Vaccines Sales and Market Share by Application (2011-2016)
Table Global Prophylactic Human Vaccines Sales Share by Application (2011-2016)
Figure Sales Market Share of Prophylactic Human Vaccines by Application (2011-2016)
Figure Global Prophylactic Human Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
Figure USA Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
Figure USA Prophylactic Human Vaccines Sales Price Trend (2011-2016)
Table USA Prophylactic Human Vaccines Sales by Manufacturers (2011-2016)
Table USA Prophylactic Human Vaccines Market Share by Manufacturers (2011-2016)
Table USA Prophylactic Human Vaccines Sales by Type (2011-2016)
Table USA Prophylactic Human Vaccines Market Share by Type (2011-2016)
Table USA Prophylactic Human Vaccines Sales by Application (2011-2016)
Table USA Prophylactic Human Vaccines Market Share by Application (2011-2016)
Figure China Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
Figure China Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
Figure China Prophylactic Human Vaccines Sales Price Trend (2011-2016)
Table China Prophylactic Human Vaccines Sales by Manufacturers (2011-2016)
Table China Prophylactic Human Vaccines Market Share by Manufacturers (2011-2016)
Table China Prophylactic Human Vaccines Sales by Type (2011-2016)
Table China Prophylactic Human Vaccines Market Share by Type (2011-2016)
Table China Prophylactic Human Vaccines Sales by Application (2011-2016)
Table China Prophylactic Human Vaccines Market Share by Application (2011-2016)
Figure Europe Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
Figure Europe Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
Figure Europe Prophylactic Human Vaccines Sales Price Trend (2011-2016)
Table Europe Prophylactic Human Vaccines Sales by Manufacturers (2011-2016)
Table Europe Prophylactic Human Vaccines Market Share by Manufacturers (2011-2016)
Table Europe Prophylactic Human Vaccines Sales by Type (2011-2016)
Table Europe Prophylactic Human Vaccines Market Share by Type (2011-2016)
Table Europe Prophylactic Human Vaccines Sales by Application (2011-2016)
Table Europe Prophylactic Human Vaccines Market Share by Application (2011-2016)
Figure Japan Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
Figure Japan Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
Figure Japan Prophylactic Human Vaccines Sales Price Trend (2011-2016)
Table Japan Prophylactic Human Vaccines Sales by Manufacturers (2011-2016)
Table Japan Prophylactic Human Vaccines Market Share by Manufacturers (2011-2016)
Table Japan Prophylactic Human Vaccines Sales by Type (2011-2016)
Table Japan Prophylactic Human Vaccines Market Share by Type (2011-2016)
Table Japan Prophylactic Human Vaccines Sales by Application (2011-2016)
Table Japan Prophylactic Human Vaccines Market Share by Application (2011-2016)
Figure India Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
Figure India Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
Figure India Prophylactic Human Vaccines Sales Price Trend (2011-2016)
Table India Prophylactic Human Vaccines Sales by Manufacturers (2011-2016)
Table India Prophylactic Human Vaccines Market Share by Manufacturers (2011-2016)
Table India Prophylactic Human Vaccines Sales by Type (2011-2016)
Table India Prophylactic Human Vaccines Market Share by Type (2011-2016)
Table India Prophylactic Human Vaccines Sales by Application (2011-2016)
Table India Prophylactic Human Vaccines Market Share by Application (2011-2016)
Figure Southeast Asia Prophylactic Human Vaccines Sales and Growth Rate (2011-2016)
Figure Southeast Asia Prophylactic Human Vaccines Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Prophylactic Human Vaccines Sales Price Trend (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Sales by Manufacturers (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Market Share by Manufacturers (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Sales by Type (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Market Share by Type (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Sales by Application (2011-2016)
Table Southeast Asia Prophylactic Human Vaccines Market Share by Application (2011-2016)
Table ALK - Abello A/S (Denmark) Basic Information List
Table ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Altimmune, Inc. (US) Basic Information List
Table Altimmune, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Altimmune, Inc. (US) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Bavarian Nordic A/S (Denmark) Basic Information List
Table Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List
Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Bharat Biotech International Limited (India) Basic Information List
Table Bharat Biotech International Limited (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bharat Biotech International Limited (India) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Hualan Biological Engineering Inc. (China) Basic Information List
Table Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information List
Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table MedImmune (US) Basic Information List
Table MedImmune (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MedImmune (US) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. (US) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Pfizer Inc. (US) Basic Information List
Table Pfizer Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (US) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Sanofi Pasteur SA (France) Basic Information List
Table Sanofi Pasteur SA (France) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Pasteur SA (France) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Serum Institute of India Pvt. Ltd. (India) Basic Information List
Table Serum Institute of India Pvt. Ltd. (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Serum Institute of India Pvt. Ltd. (India) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Shanghai BravoBio Co., Ltd. (China) Basic Information List
Table Shanghai BravoBio Co., Ltd. (China) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shanghai BravoBio Co., Ltd. (China) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Seqirus (UK) Basic Information List
Table Seqirus (UK) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Seqirus (UK) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table SK Chemicals Co., Ltd. (Korea) Basic Information List
Table SK Chemicals Co., Ltd. (Korea) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure SK Chemicals Co., Ltd. (Korea) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited (Japan) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Zydus Cadila (India) Basic Information List
Table Zydus Cadila (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zydus Cadila (India) Prophylactic Human Vaccines Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccines
Figure Manufacturing Process Analysis of Prophylactic Human Vaccines
Figure Prophylactic Human Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccines Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccines
Table Distributors/Traders List
Figure Global Prophylactic Human Vaccines Sales and Growth Rate Forecast (2016-2021)
Figure Global Prophylactic Human Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Global Prophylactic Human Vaccines Sales Forecast by Regions (2016-2021)
Table Global Prophylactic Human Vaccines Sales Forecast by Type (2016-2021)
Table Global Prophylactic Human Vaccines Sales Forecast by Application (2016-2021)